Cisplatin-Induced Nephrotoxicity; Protective Supplements and Gender Differences
about
Analysis of adverse events of renal impairment related to platinum-based compounds using the Japanese Adverse Drug Event Report database.S100A9 regulates cisplatin chemosensitivity of squamous cervical cancer cells and related mechanismWhortleberry protects kidney against the cisplatin-induced nephrotoxicity: an experimental study
P2860
Cisplatin-Induced Nephrotoxicity; Protective Supplements and Gender Differences
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Cisplatin-Induced Nephrotoxicity; Protective Supplements and Gender Differences
@en
Cisplatin-Induced Nephrotoxicity; Protective Supplements and Gender Differences
@nl
type
label
Cisplatin-Induced Nephrotoxicity; Protective Supplements and Gender Differences
@en
Cisplatin-Induced Nephrotoxicity; Protective Supplements and Gender Differences
@nl
prefLabel
Cisplatin-Induced Nephrotoxicity; Protective Supplements and Gender Differences
@en
Cisplatin-Induced Nephrotoxicity; Protective Supplements and Gender Differences
@nl
P2093
P2860
P1476
Cisplatin-Induced Nephrotoxicity; Protective Supplements and Gender Differences
@en
P2093
Alireza Rezaei
Azam Mansouri
Bahar Mazaheri
Fariba Azarkish
Farzaneh Ashrafi
Farzaneh Zeinali
Fatemeh Eshraghi Jazi
Fatemeh Moslemi
Maryam Maleki
Maryam Moeini
P2860
P304
P356
10.22034/APJCP.2017.18.2.295
P577
2017-02-01T00:00:00Z